Importance of early complex evaluation in high-risk pregnancy associated to diabetes mellitus. Case presentation and review of the literature

Romanian Journal of Morphology and Embryology

Volumn 52, Issue 3 SUPPL., 2012, Pages 1127-1132

  Gheorman, Lavinia ^a   Iliescu, D ^a   Ceauşu, Iuliana ^b   Paulescu, Daniela ^c   Plesea I E ^a   Gheorman, V ^a  

^a UNIVERSITY OF MEDICINE AND PHARMACY OF CRAIOVA   (Romania)

^b CAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^c Department of Obstetrics and Gynecology   (Greece)

Author keywords

Congenital heart defects; First trimester screening; Gestational diabetes; Spina bifida

Indexed keywords

ADULT; CASE REPORT; CHORION VILLUS; ECHOGRAPHY; FEMALE; FETUS ECHOGRAPHY; HIGH RISK PREGNANCY; HUMAN; HYPOPLASTIC LEFT HEART SYNDROME; PATHOLOGY; PREGNANCY; PREGNANCY DIABETES MELLITUS; REVIEW; SPINAL DYSRAPHISM;

ADULT; CHORIONIC VILLI; DIABETES, GESTATIONAL; FEMALE; HUMANS; HYPOPLASTIC LEFT HEART SYNDROME; PREGNANCY; PREGNANCY, HIGH-RISK; SPINAL DYSRAPHISM; ULTRASONOGRAPHY, PRENATAL;

EID: 84858168254     PISSN: 12200522     EISSN: 20668279     Source Type: Journal    
DOI: None     Document Type: Article

References (67)

1. Wilson RD, Wilson RD, Johnson JA, Summers A, Wyatt P, Allen V, Gagnon A, Langlois S, Blight C, Money DM, Boucher M, Gruslin A, Mackinnon CJ, Paquet C, van Schalkwyk J, Cohen HR, Steben M, Wong T, Yudin MH, Society of Obstetricians and Gynecologists of Canada, Principles of human teratology: drug, chemical, and infectious exposure. SOGC Clinical Practice Guidelines, No. 199, November 2007, J Obstet Gynaecol Can, 2007, 29(11):911-926.
2. Health Canada, Congenital Anomalies in Canada. A Perinatal Health Report, 2002, Minister of Public Works and Government Services Canada, Ottawa, 2002.
3. Aberg A, Westbom L, Källén B, Congenital malformations among infants whose mothers had gestational diabetes or preexisting diabetes, Early Hum Dev, 2001, 61(2):85-95.
4. Martínez-Frías ML, Bermejo E, Rodríguez-Pinilla E, Prieto L, Frías JL, Epidemiological analysis of outcomes of pregnancy in gestational diabetic mothers, Am J Med Genet, 1998, 78(2):140-145.
5. Towner D, Kjos SL, Leung B, Montoro MM, Xiang A, Mestman JH, Buchanan TA, Congenital malformations in pregnancies complicated by NIDDM: increase risk from poor maternal metabolic control but not from exposure to sulfonylurea drugs, Diabetes Care, 1995, 18(11):1446-1451.
6. Meltzer SJ, Ryan EA, Feig DS, Thompson D, Snyder J, Preconception care for women with diabetes, Canadian Diabetes Association, Clinical Practice Guidelines, 2003.
7. Sheffield JS, Butler-Koster, Casey BM, McIntire DD, Leveno KJ, Maternal diabetes mellitus and infant malformations, Obstet Gynecol, 2002, 100(5 Pt 1):925-930.
8. Sharpe PB, Chan A, Haan EA, Hiller JE, Maternal diabetes and congenital anomalies in South Australia 1986-2000: a population-based cohort study, Birth Defects Res A Clin Mol Teratol, 2005, 73(9):605-611.
9. Casson IF, Clarke CA, Howard CV, McKendrick O, Pennycook S, Pharoah POD, Platt MJ, Stanisstreet M, van Velszen D, Walkinshaw S, Outcomes of pregnancy in insulin dependent diabetic women: results of a five year population cohort study, BMJ, 1997, 315(7103):275-278.
10. Evers IM, de Valk HW, Visser GHA, Risk of complications of pregnancy in women with type 1 diabetes: nationwide prospective study in the Netherlands, BMJ, 2004, 328(7445):915.
11. Jensen DM, Damm P, Moelsted-Pedersen L, Ovesen P, Westergaard JG, Moeller M, Beck-Nielsen H, Outcomes in type 1 diabetic pregnancies: a nationwide, populationbased study, Diabetes Care, 2004, 27(12):2819-2823.
12. Langer O, Conway DL, Level of glycemia and perinatal outcome in pregestational diabetes, J Matern Fetal Med, 2000, 9(1):35-41.
13. American Diabetes Association, Gestational diabetes mellitus, Diabetes Care, 2002, 25(Suppl 1):S82-S84.
14. Temple R, Aldridge V, Greenwood R, Heyburn P, Sampson M, Stanley K, Association between outcome of pregnancy and glycaemic control in early pregnancy in type 1 diabetes: population based study, BMJ, 2002, 325(7375):1275-1276.
15. The Diabetes Control Complications Trial Research Group, Pregnancy outcomes in the Diabetes Control and Complications Trial, Am J Obstet Gynecol, 1996, 174(4):1343-1353.
16. Schaefer-Graf UM, Buchanan TA, Xiang A, Songster G, Montoro M, Kjos SL, Patterns of congenital anomalies and relationship to initial maternal fasting glucose levels in pregnancies complicated by type 2 and gestational diabetes, Am J Obstet Gynecol, 2000, 182(2):313-320.
17. Suhonen L, Hiilesmaa V, Teramo K, Glycaemic control during early pregnancy and fetal malformations in women with type I diabetes mellitus, Diabetologia, 2000, 43(1):79-82.
18. Woolderink JM, van Loon AJ, Storms F, de Heide L, Hoogenberg K, Use of insulin glargine during pregnancy in seven type 1 diabetic women, Diabetes Care, 2005, 28(10):2594-2595.
19. Watkins ML, Rasmussen SA, Honein MA, Botto LD, Moore CA, Maternal obesity and risk of birth defects, Pediatrics, 2003, 111(5 Part 2):1152-1158.
20. Hofmann T, Horstmann G, Stammberger I, Evaluation of the reproductive toxicity and embryotoxicity of insulin glargine (LANTUS) in rats and rabbits, Int J Toxicol, 2002, 21(3):181-189.
21. Shaw GM, Velie EM, Schaffer D, Risk of neural tube defectaffected pregnancies among obese women, JAMA, 1996, 275(14):1093-1096.
22. Cedergren ML, Källén BAJ, Maternal obesity and infant heart defects, Obes Res, 2003, 11(9):1065-1071.
23. Moore LL, Singer MR, Bradlee ML, Rothman KJ, Milunsky A, A prospective study of the risk of congenital defects associated with maternal obesity and diabetes mellitus, Epidemiology, 2000, 11(6):689-694.
24. Martínez-Frías ML, Frías JP, Bermejo E, Rodríguez-Pinilla E, Prieto L, Frías JL, Pre-gestational maternal body mass index predicts an increased risk of congenital malformations in infants of mothers with gestational diabetes, Diabet Med, 2005, 22(6):775-781.
25. American Diabetes Association, Diagnosis and classification of diabetes mellitus, Diabetes Care, 2005, 28(Suppl 1):S37-S42.
26. Kousseff BG, Diabetic embryopathy, Curr Opin Pediatr, 1999, 11(4):348-352.
27. Zaw W, Stone DG, Caudal Regression Syndrome in twin pregnancy with type II diabetes, J Perinatol, 2002, 22(2):171-174.
28. Lombardi CM, Bellotti M, Fesslova V, Cappellini A, Fetal echocardiography at the time of the nuchal translucency scan, Ultrasound Obstet Gynecol, 2007, 29(3):249-257.
29. Chaoui R, Benoit B, Mitkowska-Wozniak H, Heling KS, Nicolaides KH, Assessment of intracranial translucency (IT) in the detection of spina bifida at the 11-13-week scan, Ultrasound Obstet Gynecol, 2009, 34(3):249-252.
30. Lachmann R, Chaoui R, Moratalla J, Picciarelli G, Nicolaides KH, Posterior brain in fetuses with open spina bifida at 11 to 13 weeks, Prenat Diagn, 2011, 31(1):103-106.
31. Anderson JL, Waller DK, Canfield MA, Shaw GM, Watkins ML, Werler MM, Maternal obesity, gestational diabetes, and central nervous system birth defects, Epidemiology, 2005, 16(1):87-92.
32. Kitzmiller JL, Gavin LA, Gin GD, Jovanovic-Peterson L, Main EK, Zigrang WD, Preconception care of diabetes. Glycemic control prevents congenital anomalies, JAMA, 1991, 265(6):731-736.
33. Holing EV, Beyer CS, Brown ZA, Connell FA, Why don't women with diabetes plan their pregnancies? Diabetes Care, 1998, 21(6):889-895.
34. Steel JM, Johnstone FD, Hepburn DA, Smith AF, Can prepregnancy care of diabetic women reduce the risk of abnormal babies? BMJ, 1990, 301(6760):1070-1074.
35. Ray JG, O'Brien TE, Chan WS, Preconception care and the risk of congenital anomalies in the offspring of women with diabetes mellitus: a meta-analysis, QJM, 2001, 94(8):435-444.
36. McElvy SS, Miodovnik M, Rosenn B, Khoury JC, Siddiqi T, Dignan PSJ, Tsang RC, A focused preconceptional and early pregnancy program in women with type 1 diabetes reduces perinatal mortality and malformation rates to general population levels, J Matern Fetal Med, 2000, 9(1):14-20.
37. Boulot P, Chabbert-Buffet N, d'Ercole C, Floriot M, Fontaine P, Fournier A, Gillet JY, Gin H, Grandperret-Vauthier S, Geudj AM, Guionnet B, Hauguel-de-Mouzon S, Hieronimus S, Hoffet M, Jullien D, Lamotte MF, Lejeune V, Lepercq J, Lorenzi F, Mares P, Miton A, Penfornis A, Pfister B, Renard E, Rodier M, Roth P, Sery GA, Timsit J, Valat AS, Vambergue A, Verier-Mine O; Diabetes and Pregnancy Group, France, French multicentric survey of outcome of pregnancy in women with pregestational diabetes, Diabetes Care, 2003, 26(11):2990-2993.
38. Willhoite MB, Bennert HW Jr, Palomaki GE, Zaremba MM, Herman WH, Williams JR, Spear NH, The impact of preconception counseling on pregnancy outcomes. The experience of the Maine Diabetes in Pregnancy Program, Diabetes Care, 1993, 16(2):450-455.
39. Miodovnik M, Mimouni F, Dignan PS, Berk MA, Ballard JL, Siddiqi TA, Khoury J, Tsang RC, Major malformations in infants of IDDM women. Vasculopathy and early firsttrimester poor glycemic control, Diabetes Care, 1988, 11(9):713-718.
40. Dunne FP, Chowdhury TA, Hartland A, Smith T, Brydon PA, McConkey C, Nicholson HO, Pregnancy outcome in women with insulin-dependent diabetes mellitus complicated by nephropathy, QJM, 1999, 92(8):451-454.
41. Schaefer UM, Songster G, Xiang A, Berkowitz K, Buchanan TA, Kjos SL, Congenital malformations in offspring of women with hyperglycemia first detected during pregnancy, Am J Obstet Gynecol, 1997, 177(5): 1165-1171.
42. Huttly W, Rudnicka A, Wald NJ, Second-trimester prenatal screening markers for Down syndrome in women with insulin-dependent diabetes mellitus, Prenat Diagn, 2004, 24(10):804-807.
43. American Diabetes Association, Preconception care of women with diabetes, Diabetes Care, 2003, 27(Suppl 1): S76-S78.
44. Allen VM, Armson BA, Wilson RD, Allen VM, Blight C, Gagnon A, Johnson JA, Langlois S, Summers A, Wyatt P, Farine D, Armson BA, Crane J, Delisle MF, Keenan-Lindsay L, Morin V, Schneider CE, Van Aerde J, Society of Obstetricians and Gynecologists of Canada, Teratogenicity associated with pre-existing and gestational diabetes, J Obstet Gynaecol Can, 2007, 29(11):927-944.
45. Becker R, Wegner RD, Detailed screening for fetal anomalies and cardiac defects at the 11-13-week scan, Ultrasound Obstet Gynecol, 2006, 27(6):613-618.
46. Dahlheim M, Witsch M, Dermirakca S, Lorenz C, Schaible T, Congenital diaphragmatic hernia - results of an ECMO-center, Klin Pädiatr, 2003, 215(4):213-222.
47. Nicolaides KH, Azar G, Byrne D, Mansur C, Marks K, Fetal nuchal translucency: ultrasound screening for chromosomal defects in first trimester of pregnancy, BMJ, 1992, 301(6831):867-869.
48. Snijders RJ, Noble P, Sebire N, Souka A, Nicolaides KH, UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10-14 weeks of gestation. Fetal Medicine Foundation First Trimester Screening Group, Lancet, 1998, 352(9125):343-346.
49. Dolkart LA, Reimers FT, Transvaginal fetal echocardiography in early pregnancy: normative data, Am J Obstet Gynecol, 1991, 165(3):688-691.
50. Gembruch U, Knöpfle G, Bald R, Hansmann M, Early diagnosis of fetal congenital heart disease by transvaginal echocardiography, Ultrasound Obstet Gynecol, 1993, 3(5):310-317.
51. Haak MC, Twisk JW, van Vugt JM, How successful is fetal echocardiographic examination in the first trimester of pregnancy? Ultrasound Obstet Gynecol, 2002, 20(1):9-13.
52. Hernádi L, Töröcsik M, Screening for fetal anomalies in the 12th week of pregnancy by transvaginal sonography in an unselected population, Prenat Diagn, 1997, 17(8):753-759.
53. Economides DL, Braithwaite JM, First trimester ultrasonographic diagnosis of fetal structural abnormalities in a low risk population, Br J Obstet Gynaecol, 1998, 105(1):53-57.
54. D'Ottavio G, Mandruzzato G, Meir YJ, Rustico MA, Fischer-Tamaro L, Conoscenti G, Natale R, Comparisons of first and second trimester screening for fetal anomalies, Ann N Y Acad Sci, 1998, 847:200-209.
55. Carvalho MHG, Brizot ML, Lopes LM, Chiba CH, Miyadahira S, Zugaib M, Detection of fetal structural abnormalities at the 11-14 week ultrasound scan, Prenat Diagn, 2002, 22(1):1-4.
56. Taipale P, Ammälä M, Salonen R, Hiilesmaa V, Two-stage ultrasonography in screening for fetal anomalies at 13-14 and 18-22 weeks of gestation, Acta Obstet Gynecol Scand, 2004, 83(12):1141-1146.
57. Markov D, Chernev T, Dimitrova V, Mazneǐkova V, Leroy Y, Jacquemyn Y, Ramaekers P, Van Bulck B, Loquet P, Ultrasound screening and diagnosis of fetal structural abnormalities between 11-14 gestational weeks, Akush Ginekol (Sofiia), 2004, 43(3):3-10.
58. Makrydimas G, Sotiriadis A, Huggon IC, Simpson J, Sharland G, Carvalho JS, Daubeney PE, Ioannidis JP, Nuchal translucency and fetal cardiac defects: a pooled analysis of major fetal echocardiography centers, Am J Obstet Gynecol, 2005, 192(1):89-95.
59. Syngelaki A, Chelemen T, Dagklis T, Allan L, Nicolaides KH, Challenges in the diagnosis of fetal non-chromosomal abnormalities at 11-13 weeks, Prenat Diagn, 2011, 31(1): 90-102.
60. Sepulveda W, Wong AE, Fauchon DE, Fetal spinal anomalies in a first-trimester sonographic screening program for aneuploidy, Prenat Diagn, 2011, 31(1):107-114.
61. Sebire NJ, Noble PL, Thorpe-Beeston JG, Snijders RJM, Nicolaides KH, Presence of the 'lemon' sign in fetuses with spina bifida at the 10-14-week scan, Ultrasound Obstet Gynecol, 1997, 10(6):403-405.
62. Haak MC, Twisk JW, Van Vugt JM, How successful is fetal echocardiographic examination in the first trimester of pregnancy? Ultrasound Obstet Gynecol, 2002, 20(1):9-13.
63. Bradley LA, Palomaki GE, McDowell GA; ONTD Working Group; ACMG Laboratory Quality Assurance Committee, Technical standards and guidelines: prenatal screening for open neural tube defects, Genet Med, 2005, 7(5):355-369.
64. Ghi T, Pilu G, Falco P, Segata M, Carletti A, Cocchi G, Santini D, Bonasoni P, Tani G, Rizzo N, Prenatal diagnosis of open and closed spina bifida, Ultrasound Obstet Gynecol, 2006, 28(7):899-903.
65. Gasiorek-Wiens A, Tercanli S, Kozlowski P, Kossakiewicz A, Minderer S, Meyberg H, Kamin G, Germer U, Bielicki M, Hackelöer BJ, Sarlay D, Kuhn P, Klapp J, Bahlmann F, Pruggmayer M, Schneider KT, Seefried W, Fritzer E, von Kaisenberg CS; German-Speaking Down Syndrome Screening Group, Screening for trisomy 21 by fetal nuchal translucency and maternal age: a multicenter project in Germany, Austria and Switzerland, Ultrasound Obstet Gynecol, 2001, 18(6):645-648.
66. Souka AP, Pilalis A, Kavalakis Y, Kosmas Y, Antsaklis P, Antsaklis A, Assessment of fetal anatomy at the 11-14-week ultrasound examination, Ultrasound Obstet Gynecol, 2004, 24(7):730-734.
67. von Kaisenberg CS, Kuhling-von Kaisenberg H, Fritzer E, Schemm S, Meinhold-Heerlein I, Jonat W, Fetal transabdominal anatomy scanning using standard views at 11 to 14 weeks' gestation, Am J Obstet Gynecol, 2005, 192(2): 535-542.